Company profile
Sotera Health Company
NASDAQ: SHC · Healthcare · Medical - Diagnostics & Research
#146 of 1,418 Healthcare companies by revenue50th-percentile growth
EA Score
70BFH 80DQ 56GM 66SS 70
v0.1 · 65/100 weight · provisional
↑ growth stability, operating margin · ↓ listing tenure, disclosure history
Methodology →Revenue TTM
$1.2B
Rev growth YoY (TTM)
+7.4%
Net income (FY)
$77.9M
Employees
3,000
as of 2026-08-07
Market cap
$5.4B
as of 2026-08-07
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.2B$1.2B2025
Net income$77.9M$77.9M2025
Operating income$297.6M$297.6M2024
Total assets$3.3B$3.3B2025
Liabilities$2.7B$2.7B2025
Equity$606.0M$606.0M2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY21
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Service86%
Product14%
By geography
UNITED STATES54%
Europe20%
CANADA19%
Other Geographical Areas7%
The read
What is Sotera Health Company’s revenue?
Sotera Health Company booked $1.2B in FY2025 revenue, growing 5.7% year over year — about the middle of the pack among Healthcare companies we track, at a 6.7% net margin.
Peers · Healthcare
Trulieve Cannabis Corp.63CTrulieve Cannabis Corp.——Green Thumb Industries Inc.72BNovavax, Inc.69BBabylon Holdings Limited——Waystar Holding Corp.70BNeighbors
Cuyahoga →Key facts
CEOAlton E. Shader
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersBroadview Heights, OH
ExchangeNASDAQ: SHC
Employees3,000
IPO date2020-11-20
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.